Keyt Bruce 4
4 · IGM Biosciences, Inc. · Filed Mar 28, 2024
Insider Transaction Report
Form 4
Keyt Bruce
Chief Scientific Officer
Transactions
- Award
Common Stock
2024-03-26+24,019→ 195,875 total
Holdings
- 4,039(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]These securities are restricted stock units (RSUs), granted pursuant to the election by the Reporting Person to receive RSUs in lieu of an earned cash bonus for performance in fiscal year 2023. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 100% of the RSUs shall vest in December 2024, provided that the Reporting Person remains a service provider through the vesting date.
- [F2]The securities are held directly by the reporting person's spouse.